EMAIL THIS PAGE TO A FRIEND

Journal of immunology (Baltimore, Md. : 1950)

IL-10/HMOX1 signaling modulates cochlear inflammation via negative regulation of MCP-1/CCL2 expression in cochlear fibrocytes.


PMID 25780042

Abstract

Cochlear inflammatory diseases, such as tympanogenic labyrinthitis, are associated with acquired sensorineural hearing loss. Although otitis media is extremely frequent in children, tympanogenic labyrinthitis is not commonly observed, which suggests the existence of a potent anti-inflammatory mechanism modulating cochlear inflammation. In this study, we aimed to determine the molecular mechanism involved in cochlear protection from inflammation-mediated tissue damage, focusing on IL-10 and hemoxygenase-1 (HMOX1) signaling. We demonstrated that IL-10Rs are expressed in the cochlear lateral wall of mice and rats, particularly in the spiral ligament fibrocytes (SLFs). The rat SLF cell line was found to inhibit nontypeable Haemophilus influenzae (NTHi)-induced upregulation of monocyte chemotactic protein-1 (MCP-1; CCL2) in response to IL-10. This inhibition was suppressed by silencing IL-10R1 and was mimicked by cobalt Protoporphyrin IX and CO-releasing molecule-2. In addition, IL-10 appeared to suppress monocyte recruitment through reduction of NTHi-induced rat SLF cell line-derived chemoattractants. Silencing of HMOX1 was found to attenuate the inhibitory effect of IL-10 on NTHi-induced MCP-1/CCL2 upregulation. Chromatin immunoprecipitation assays showed that IL-10 inhibits NTHi-induced binding of p65 NF-κB to the distal motif in the promoter region of MCP-1/CCL2, resulting in suppression of NTHi-induced NF-κB activation. Furthermore, IL-10 deficiency appeared to significantly affect cochlear inflammation induced by intratympanic injections of NTHi. Taken together, our results suggest that IL-10/HMOX1 signaling is involved in modulation of cochlear inflammation through inhibition of MCP-1/CCL2 regulation in SLFs, implying a therapeutic potential for a CO-based approach for inflammation-associated cochlear diseases.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA003258
Anti-GABPA antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV100832
Anti-GABPA antibody produced in rabbit, IgG fraction of antiserum
HPA028791
Anti-GABPA antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1410470
Anti-GABPA antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB4501989
Anti-NF-κB p105 antibody produced in rabbit, affinity isolated antibody
SAB4300301
Anti-NFKB1 (Ab-337) antibody produced in rabbit, affinity isolated antibody
SAB4300302
Anti-NFKB1 (Ab-893) antibody produced in rabbit, affinity isolated antibody
SAB4300303
Anti-NFKB1 (Ab-907) antibody produced in rabbit, affinity isolated antibody
SAB4300554
Anti-NFKB1 (Ab-927) antibody produced in rabbit, affinity isolated antibody
SAB4300498
Anti-NFKB1 (Ab-932) antibody produced in rabbit, affinity isolated antibody
AV38413
Anti-NFKB1 antibody produced in rabbit, affinity isolated antibody
HPA027305
Anti-NFKB1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2103906
Anti-NFKB1 antibody produced in rabbit, affinity isolated antibody
SRP3312 IL-10 human, Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
SRP3071 IL-10 human, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
I9276 Interleukin-10 human, ≥97% (SDS-PAGE), recombinant, expressed in baculovirus infected Sf21 cells, lyophilized powder, cell culture tested
H7541 Interleukin-10 human, IL-10, recombinant, expressed in HEK 293 cells, HumanKine®, suitable for cell culture
PLA0214
Rabbit anti-NF-kappaB1 Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
288144
Tricarbonyldichlororuthenium(II) dimer
C6Cl4O6Ru2